Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of PDE4DIP mRNA | affects expression | 21346803
|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of PDE4DIP mRNA | affects expression | 21346803
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of PDE4DIP mRNA | affects expression | 16483693
|
D016718 |
Arachidonic Acid |
Arachidonic Acid results in decreased expression of PDE4DIP mRNA | decreases expression | 16704987
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of PDE4DIP mRNA | increases expression | 15761015
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of PDE4DIP mRNA | increases expression | 20678512
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of PDE4DIP mRNA | increases expression | 18180321
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of PDE4DIP mRNA | increases expression | 15336504
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of PDE4DIP mRNA | decreases expression | 20106945
|
C014347 |
decitabine |
decitabine affects the expression of PDE4DIP mRNA | affects expression | 17145863
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PDE4DIP mRNA | affects cotreatment|increases expression | 17942748
|
D008628 |
Mercury |
Mercury results in increased expression of PDE4DIP mRNA | increases expression | 16823088
|
C025299 |
polyphenols |
polyphenols results in decreased expression of PDE4DIP mRNA | decreases expression | 16293270
|
C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of PDE4DIP mRNA | affects expression | 17440010
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PDE4DIP mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of PDE4DIP mRNA | increases expression | 19465110
|
C034613 |
triacsin C |
triacsin C results in decreased expression of PDE4DIP mRNA | decreases expression | 16704987
|
C034028 |
vanadyl sulfate |
vanadyl sulfate results in increased expression of PDE4DIP mRNA | increases expression | 16330358
|
C025643 |
vinclozolin |
vinclozolin affects the expression of PDE4DIP mRNA | affects expression | 19015723
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
8.45 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.45 | 15322242 14514962 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.55 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.94 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
4.27 | 19825857 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.27 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.37 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.93 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.62 | 19015723 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.45 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.65 | 15885639 |
MESH:D001321 |
Autistic Disorder |
|
Arachidonic Acid |
2.73 | 18582451 |
MESH:D001321 |
Autistic Disorder |
|
Mercury |
2.73 | 17497416 |
MESH:D001327 |
Autoimmune Diseases |
|
Mercury |
4.86 | 16634805 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
8.90 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.90 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.79 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.75 | 15746008 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.84 | 11985600 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
1.90 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
1.90 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.90 | 20435547 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.31 | 11589617 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.78 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
3.02 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
3.02 | 16217749 15073043 14691202 11135700 15553829 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.98 | 17123778 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.87 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.10 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
2.59 | 19215824 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.35 | 18670907 18850075 16120746 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Mercury |
3.44 | 10334427 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
3.62 | 14694615 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
6.52 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.52 | 12371664 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.14 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.72 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
7.72 | 16105132 15861022 17681005 17110522 16919318 17333356 11677210 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.09 | 15668235 8697196 12621046 15340226 16354765 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
4.02 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
4.02 | 16293270 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
2.58 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.58 | 18981723 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
9.13 | 15095906 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
9.13 | 14669216 17141729 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.17 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
2.46 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.46 | 20055451 10048152 15322242 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.32 | 14966744 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.00 | 18551238 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.08 | 15213294 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Mercury |
3.78 | 16823706 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
vanadyl sulfate |
4.35 | 16684804 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.66 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
8.98 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
8.98 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
8.98 | 19370779 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.98 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.74 | 11462148 |
MESH:D004487 |
Edema |
|
Arachidonic Acid |
7.05 | 15177302 9599246 16716910 7990266 11698051 9831321 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.05 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.90 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.17 | 12538720 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.12 | 19294695 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.00 | 9294722 10568697 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
2.30 | 12903497 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.00 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
12.97 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
12.97 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
12.97 | 15345470 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.44 | 11858732 |
MESH:D005334 |
Fever |
|
Arachidonic Acid |
4.64 | 11852909 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.44 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.44 | 20067830 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.24 | 16904648 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
4.93 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.30 | 16417039 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.21 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.59 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.47 | 19215824 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.32 | 11294989 10048152 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.41 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.32 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.88 | 15340226 12621046 16120746 |
MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
5.75 | 17440010 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.05 | 18606429 16959395 15340226 16354765 8697196 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.92 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.92 | 18670907 18850075 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.80 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.44 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
11.16 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
11.16 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
11.16 | 16467254 |
MESH:D007249 |
Inflammation |
|
Arachidonic Acid |
8.45 | 17371808 15177302 9831321 |
MESH:D007249 |
Inflammation |
|
polyphenols |
8.45 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
8.45 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
3.27 | 16393666 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.32 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.44 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.26 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Mercury |
6.26 | 17934191 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
7.21 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.21 | 12371664 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
6.42 | 15070760 |
MESH:D007938 |
Leukemia |
|
decitabine |
6.42 | 19235587 18980019 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.78 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.30 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.41 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
9.52 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
9.52 | 17236224 18454857 19117987 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
3.98 | 17050201 16467208 19850784 20471514 16968895 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
3.98 | 19010910 18206229 18460780 18704418 17679729 19387464 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.46 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
3.20 | 16112521 15213294 11468182 16823087 16331271 17712046 19642359 12712474 15748426 17869043 12018890 16891316 19225113 11161223 16966277 17649720 17217047 9834237 16330433 17107899 15622746 19075265 19035177 12679006 15336539 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.34 | 16882451 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.72 | 16417039 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.24 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
polyphenols |
2.78 | 16698588 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
7.35 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
7.35 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.35 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
9.72 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
9.72 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
9.72 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.33 | 15213294 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
2.29 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.29 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.40 | 19470736 |
MESH:D008545 |
Melanoma |
|
decitabine |
2.24 | 16505122 17785578 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.79 | 16801185 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
7.33 | 19417148 11468182 19549372 15949261 14977855 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
7.33 | 18172295 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.67 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
7.46 | 16105982 16882451 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
7.46 | 19010910 19157545 18608210 16882708 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.00 | 12213967 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.85 | 18551238 7678174 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.94 | 16624393 |
MESH:D009369 |
Neoplasms |
|
decitabine |
2.70 | 19116145 17925555 19470736 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.44 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.27 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
9.53 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.53 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
3.10 | 10525206 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
9.07 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
9.07 | 14694615 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.98 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
4.96 | 12452020 16624393 19769630 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
4.96 | 19331143 19259094 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
5.37 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
5.37 | 19294695 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.67 | 11578682 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.14 | 19927285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.25 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.54 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.20 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
16.22 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
16.22 | 11118676 11399792 11222880 11896295 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
16.22 | 18042343 19015723 18220299 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.71 | 17616702 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
4.93 | 18220299 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.19 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
3.35 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
3.35 | 16740699 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
4.93 | 18629315 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.30 | 16919318 15861022 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.22 | 16882103 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.78 | 10548101 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.82 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.38 | 19155313 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
3.94 | 16646077 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.52 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
5.56 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.56 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.94 | 16709447 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
2.56 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.56 | 19037991 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.97 | 16684133 16045194 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
5.25 | 17997062 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.60 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.13 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.90 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
7.26 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
7.26 | 17967635 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.95 | 15213294 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
8.32 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
8.32 | 12845720 12973940 20435036 11780464 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
8.32 | 17616700 19087683 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.31 | 10091137 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.01 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.28 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
4.91 | 17785578 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.98 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.59 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.52 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.25 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.44 | 17120751 |